Streetbeat News

Earnings

NTAP

NetApp (NTAP) is expected to report earnings growth, but lacks the key ingredients for an earnings beat in its upcoming report.

Portfolio Pulse from

November 14, 2024 | 4:15 pm

BIGC

Wall Street analysts have set a consensus price target for BigCommerce (BIGC), suggesting a potential 36.7% upside. Despite skepticism about the effectiveness of price targets, positive earnings estimate revisions indicate a possible near-term stock price increase.

Portfolio Pulse from

November 14, 2024 | 4:15 pm

DE

Deere (DE) is expected to report a decline in its Q4 earnings, as it lacks the right combination of key ingredients for an earnings beat. Investors should prepare for potentially disappointing results.

Portfolio Pulse from

November 14, 2024 | 4:15 pm

IPOOF

INPLAY OIL CP (IPOOF) reported break-even earnings for Q3, missing the Zacks Consensus Estimate of $0.03 per share. This is a decline from $0.06 per share a year ago.

Portfolio Pulse from

November 14, 2024 | 4:15 pm

PAGS

PagSeguro Digital Ltd. (PAGS) reported Q3 earnings of $0.32 per share, surpassing the Zacks Consensus Estimate of $0.30 per share.

Portfolio Pulse from

November 14, 2024 | 4:15 pm

CRIS

Curis, Inc. (CRIS) held its Q3 2024 earnings call, discussing financial and operational updates with key executives and analysts.

Portfolio Pulse from

November 14, 2024 | 4:15 pm

RDCM

Radcom Ltd. reported a 20% increase in Q3 2024 revenue, driven by 5G and AI advancements. The company achieved a non-GAAP net income of $3.7 million with a 24% margin, and 70% of its revenue is recurring. Partnerships with AT&T, DISH, and Rakuten Mobile support its growth.

Portfolio Pulse from

November 14, 2024 | 4:15 pm

CSV

Carriage Services (CSV) has a potential upside of 25.3% according to Wall Street analysts' price targets. Positive trends in earnings estimate revisions could support this potential rally.

Portfolio Pulse from

November 14, 2024 | 4:15 pm

ESTC

Elastic (ESTC) is expected to report earnings next week, but it may not have the right combination of factors to beat earnings expectations.

Portfolio Pulse from

November 14, 2024 | 4:15 pm

SWTX

SpringWorks Therapeutics (SWTX) is projected by Wall Street analysts to have a potential upside of 92.7% based on the mean of their price targets. Despite the historical ineffectiveness of this metric, the consensus among analysts in raising earnings estimates suggests a positive outlook for the stock.

Portfolio Pulse from

November 14, 2024 | 4:15 pm